Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuen Chan

Showing results (231-240 of 418) with videos related to

Pageof 42
Sort By:
Antiviral Therapy|August 24, 2007
Virological response to different combination regimes of peginterferon alpha-2b and lamivudine in hepatitis B e antigen positive chronic hepatitis BHenry Lik-Yuen Chan, Vincent Wai-Sun Wong, Angel Mei-Ling Chim, et al.
Alimentary Pharmacology & Therapeutics|August 21, 2018
Chronic kidney disease progression in patients with chronic hepatitis B on tenofovir, entecavir, or no treatmentGrace Lai-Hung Wong, Henry Lik-Yuen Chan, Yee-Kit Tse, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 18, 2009
Hepatitis B virus genotype C is associated with more severe liver fibrosis than genotype BHenry Lik-Yuen Chan, Grace Lai-Hung Wong, Chi-Hang Tse, et al.
International Journal of Cardiology|February 15, 2012
Comparison of left ventricular reverse remodeling induced by cardiac contractility modulation and cardiac resynchronization therapy in heart failure patients with different QRS durationsQing Zhang, Yat-Sun Chan, Yu-Jia Liang, et al.
Journal of Medical Virology|September 5, 2002
Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantationHenry Lik-Yuen Chan, Albert Ka-Keung Chui, Wan-Yee Lau, et al.
Alimentary Pharmacology & Therapeutics|September 17, 2019
Tenofovir disoproxil fumarate reduces hepatocellular carcinoma, decompensation and death in chronic hepatitis B patients with cirrhosisKen Liu, Jonggi Choi, An Le, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 29, 2018
Chronic Hepatitis B Increases Liver-Related Mortality of Patients With Acute Hepatitis E: A Territorywide Cohort Study From 2000 to 2016Jimmy Che-To Lai, Grace Lai-Hung Wong, Terry Cheuk-Fung Yip, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 17, 2017
Effects of Diabetes and Glycemic Control on Risk of Hepatocellular Carcinoma After Seroclearance of Hepatitis B Surface AntigenTerry Cheuk-Fung Yip, Vincent Wai-Sun Wong, Henry Lik-Yuen Chan, et al.
European Journal of Internal Medicine|December 8, 2020
Negligible HCC risk during stringently defined untreated immune-tolerant phase of chronic hepatitis BHye Won Lee, Young Eun Chon, Beom Kyung Kim, et al.
Journal of Hepatology|November 22, 2024
Histological severity, clinical outcomes and impact of antiviral treatment in indeterminate phase of chronic hepatitis B: A systematic review and meta-analysisJimmy Che-To Lai, Grace Lai-Hung Wong, Yee-Kit Tse, et al.
Pageof 42

Showing results (231-240 of 418) with videos related to

Sort By:
Pageof 42
Antiviral Therapy|August 24, 2007
Virological response to different combination regimes of peginterferon alpha-2b and lamivudine in hepatitis B e antigen positive chronic hepatitis BHenry Lik-Yuen Chan, Vincent Wai-Sun Wong, Angel Mei-Ling Chim, et al.
Alimentary Pharmacology & Therapeutics|August 21, 2018
Chronic kidney disease progression in patients with chronic hepatitis B on tenofovir, entecavir, or no treatmentGrace Lai-Hung Wong, Henry Lik-Yuen Chan, Yee-Kit Tse, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 18, 2009
Hepatitis B virus genotype C is associated with more severe liver fibrosis than genotype BHenry Lik-Yuen Chan, Grace Lai-Hung Wong, Chi-Hang Tse, et al.
International Journal of Cardiology|February 15, 2012
Comparison of left ventricular reverse remodeling induced by cardiac contractility modulation and cardiac resynchronization therapy in heart failure patients with different QRS durationsQing Zhang, Yat-Sun Chan, Yu-Jia Liang, et al.
Journal of Medical Virology|September 5, 2002
Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantationHenry Lik-Yuen Chan, Albert Ka-Keung Chui, Wan-Yee Lau, et al.
Alimentary Pharmacology & Therapeutics|September 17, 2019
Tenofovir disoproxil fumarate reduces hepatocellular carcinoma, decompensation and death in chronic hepatitis B patients with cirrhosisKen Liu, Jonggi Choi, An Le, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 29, 2018
Chronic Hepatitis B Increases Liver-Related Mortality of Patients With Acute Hepatitis E: A Territorywide Cohort Study From 2000 to 2016Jimmy Che-To Lai, Grace Lai-Hung Wong, Terry Cheuk-Fung Yip, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 17, 2017
Effects of Diabetes and Glycemic Control on Risk of Hepatocellular Carcinoma After Seroclearance of Hepatitis B Surface AntigenTerry Cheuk-Fung Yip, Vincent Wai-Sun Wong, Henry Lik-Yuen Chan, et al.
European Journal of Internal Medicine|December 8, 2020
Negligible HCC risk during stringently defined untreated immune-tolerant phase of chronic hepatitis BHye Won Lee, Young Eun Chon, Beom Kyung Kim, et al.
Journal of Hepatology|November 22, 2024
Histological severity, clinical outcomes and impact of antiviral treatment in indeterminate phase of chronic hepatitis B: A systematic review and meta-analysisJimmy Che-To Lai, Grace Lai-Hung Wong, Yee-Kit Tse, et al.
Pageof 42